Commentary · 29 Dec 2025
Mini reviewPublished 9 Apr 2024
Effector-independent in vivo Activity of a Strong Influenza B Neuraminidase Widely Neutralizing Antibody
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Influenza B virus poses a significant public health threat, particularly during seasonal outbreaks. Traditional treatments and vaccines have limited efficacy against diverse and evolving strains. In this context, antibodies targeting conserved viral components offer a promising therapeutic avenue. This article delves into the effector-independent in vivo activity of a robust influenza B neuraminidase (NA) widely neutralizing antibody (WNA). We explore the antibody’s mechanism, efficacy, and potential implications for future influenza therapies. Our literature review examines previous research on NA-targeting antibodies, while the discussion considers the antibody's therapeutic potential, advantages, and limitations. The conclusion highlights the significance of these findings in the broader context of influenza management.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Diseases and Medicine.
Brief report · 29 Dec 2025
Advancing Infectious Disease Diagnostics: Faster, Accurate, Accessible
Perspective · 29 Dec 2025
Digital Health: Revolutionizing Infectious Disease Monitoring and Response
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases and Medicine
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Manuel Gellar”
